Duality Biotherapeutics hits record high on inclusion in Stock Connect programme
** Shares of Duality Biotherapeutics Inc 9606.HK jump 14.3% to HK$415, their highest point and the biggest intraday pct gain since debut on April 15 ** The biopharmaceuticals group says it will be included as a constituent stock of the Hang Seng Composite Index and in the list of eligible shares of the Southbound Trading Link of the Shanghai-Hong Kong Stock Connect effective September 8 ** Hang Seng Biotech Index .HSHKBIO rises 1.6%, benchmark Hang Seng Index .HSI adds 0.3% (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))
Recent news on Duality Biotherapeutics
See all newsDuality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up
Brief: Duality Biotherapeutics Says Global Research And Development Collaboration And License Agreement With Genentech
Brief: Duality Biotherapeutics Obtains Acceptance From Shanghai Securities Regulatory Bureau For Counselling On Proposed RMB Share Listing
Brief: Duality Biotherapeutics Announces Share Repurchase Plan Of Up To $40 Million
Brief: Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board